secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001213900-24-001511
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phoenix Biotech SPAC extends merger deadline to Apr 8, 2024; 11,625 shares redeemed
--------------------------------------------------------------------------------

- Stockholders approved Charter and Trust amendments to allow up to three monthly extensions from Jan 8 to Apr 8, 2024.
- Sponsor deposited $22,599.96 into trust account for the first extension period.
- Redemption of 11,625 Class A shares at $11.02 per share reduced trust balance to ~$8.3M.
- Post-redemption, 6,234,582 Class A shares outstanding; 753,332 are public shares with redemption rights.
- Certificate of Correction filed Jan 4, 2024 to fix scrivener's errors in the Charter Amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024001511/0001213900-24-001511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390024001511/ea191118-8k425_phoenix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-001511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer